Skip to content

An early efficacy study of unicompartmental knee arthroplasty combined with platelet-rich plasma on knee osteoarthritis

Efficacy of unicompartmental replacement combined with platelet-rich plasma on knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102847
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone and joint diseases

Interventions

PRP group:UKA surgery combined with PRP injection
"Cocktail" group:UKA surgery combined with a "cocktail" injection
Usual care group:UKA procedure only

Sponsors

Qianxinan Prefecture People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with knee osteoarthritis diagnosed according to the 2021 edition of the Chinese Guidelines for the Diagnosis and Treatment of Osteoarthritis, whose pathological changes are mainly medial compartments of the knee joint, confirmed by imaging examination as unilateral compartment injury, and the lateral chamber structure is intact, and the patellofemoral joint is not significantly involved or only has mild degenerative changes; 2. Unilateral knee osteoarthritis; 3. Knee range of motion > 90°, flexion contracture =50 years old; 8. Good treatment compliance, agree to participate in this trial and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with language, cognition, and communication disabilities; 2. Previous history of ipsilateral hip and ankle replacement surgery; 3. Those with degenerative lesions of the contralateral compartment and patellar joint; 4. Those with severe organ dysfunction and uncontrolled infection; 5. Those who have been injected with other drugs in the knee joint cavity in the past 3 months; 6. Allergy to the drug of this study or combined with severe allergic diseases; 7. Patients with blood and endocrine system diseases; 8. Those who have recently received immunosuppressants or anticoagulants and other drugs; 9. Those with mental or consciousness disorders who are unable to cooperate with clinical treatment or examination.

Design outcomes

Primary

MeasureTime frame
Hospital for special surgery knee score;

Secondary

MeasureTime frame
Visual analogue scale;Range of motion;

Countries

China

Contacts

Public ContactWu Jun

Qianxinan Prefecture People's Hospital, Xingyi City, Guizhou Province

3142085460@qq.com+86 130 0576 5056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026